DRAVET SYNDROME (DS)
Clinical trials for DRAVET SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Epilepsy drug soticlestat safety trial ends early
Disease control TerminatedThis study looked at the long-term safety of soticlestat, an add-on seizure medicine, in children and adults with severe epilepsy syndromes like Dravet and Lennox-Gastaut. Participants took soticlestat twice daily and visited the clinic every 2-6 months. The study was terminated …
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 11:37 UTC
-
Seizure drug safety trial ends early for rare epilepsies
Disease control TerminatedThis study looked at the long-term safety of soticlestat when added to standard seizure medicines for people with Dravet syndrome or Lennox-Gastaut syndrome. It included children and adults who had already been in earlier studies. The trial was stopped early, but researchers were…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 11:29 UTC